Highlighting MML Regional Service Representatives - Insights
Our Mayo Medical Laboratory regional service representatives provide outstanding support to our clients and have the opportunity to share the Mayo Clinic mission and expertise with laboratories around the world. To gain a good understanding...
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
Our staff, our stories: Rondell Graham - Insights
Dr. Graham recalls how his upbringing influenced his outlook on life and discusses the power of investing in relationships.
Lessons from Leaders: Who Let the DOGs Out? - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing, interviews Amy Clayton, M.D., Division Chair of Anatomic Pathology at Mayo Clinic, about "disease-oriented groups," which are multidisciplinary teams formed to establish a...
Winter Activities: Safety Tips - Insights
Here in Minnesota, we have entered into the time of year that is either loved or hated by Minnesotans: winter. In honor of Winter Hazard Awareness Week, November 6–10, Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, suggests resources...
In this month's "Hot Topic," Robin Patel, M.D., discusses how the use of multiplex tests may reduce the turnaround time for identifying the cause of bloodstream infections, and how this might impact antibiotic stewardship and patient...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.